SCHEMBL9346956

SCHEMBL9346956

CCC(=O)N(c1ccc(O)c(O)c1)C1CCCCC1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.47
▸ KDM4E B2RXH2 1/20 0.47
▸ MEN1 O00255 1/20 0.47
▸ NPC1 O15118 1/20 0.47
▸ MITF O75030 1/20 0.47
▸ RAB9A P51151 1/20 0.47
▸ KMT2A Q03164 1/20 0.47
▸ PAX8 Q06710 1/20 0.47
▸ SMN1; SMN2 Q16637 1/20 0.47
▸ SERPINE1 P05121 1/20 0.43
▸ OPRM1 P35372 6/20 0.43
▸ SIGMAR1 Q99720 2/20 0.43
▸ OPRL1 P41146 1/20 0.43
▸ SLC22A1 O15245 1/20 0.41
▸ NR1I2 O75469 1/20 0.41
▸ ABCB1 P08183 1/20 0.41
▸ CHRM1 P11229 1/20 0.41
▸ DRD2 P14416 1/20 0.41
▸ ADRA2B P18089 1/20 0.41
▸ ADRA2C P18825 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9260624 0.86 KDM4E (0.59) ALDH1A1KDM4EMEN1NPC1MITF
SCHEMBL9845445 0.82 MEN1 (0.51) ALDH1A1KDM4EMEN1NPC1MITF
SCHEMBL18569422 0.79 KDM4E (0.72) ALDH1A1KDM4EMEN1NPC1MITF
SCHEMBL11436717 0.78 MEN1 (0.52) ALDH1A1KDM4EMEN1NPC1MITF
SCHEMBL9444684 0.72 ALOX15 (0.50) ALDH1A1KDM4EMEN1KMT2ASMN1; SMN2
SCHEMBL10271042 0.70 TRPM8 (0.71) ALDH1A1KDM4EMEN1NPC1MITF
SCHEMBL28157600 0.70 KDM4E (0.44) ALDH1A1KDM4EMEN1KMT2ASMN1; SMN2
SCHEMBL924111 0.69 CA12 (0.52) OPRM1SIGMAR1OPRL1SLC22A1NR1I2
SCHEMBL924943 0.69 SLC6A4 (0.67) OPRM1SIGMAR1CHRM3OPRD1SLC6A3
SCHEMBL924025 0.69 TACR1 (0.49) OPRM1SIGMAR1OPRD1SLC6A3KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0333522-B1 Catechol derivatives and pharmaceutical preparations containing same MITSUI TOATSU CHEMICALS (JP) 1994-08-17 — — EP disclosed
US-5232923-A Stimulates production of nerve growth factor; administering for treatment of regressive disorders of the central nervous system MITSUI TOATSU CHEMICALS, INCORPORATED (JP) 1993-08-03 — — US disclosed
EP-0333522-A2 Catechol derivatives and pharmaceutical preparations containing same MITSUI TOATSU CHEMICALS, Inc. (JP) 1989-09-20 — — EP disclosed
Send feedback